Human Apo-Transferrin Protein, CF 3188-AT-100MG from R&D Systems, a Bio-Techne Brand

Product Specs
ItemHuman Apo-Transferrin Protein, CF
CompanyR&D Systems, a Bio-Techne Brand
Price $146.00Supplier Page View Company Product Page
Catalog Number3188-AT-100MG
SpeciesHuman
FormatLyophilized from a 0.2 µm filtered solution in deionized water
Size100 mg (also 1 g)
Source/Expression SystemHuman Plasma
Molecule NameApo-Transferrin
ApplicationsBioactivity
Conjugate/TagUnconjugated
Molecular Weight76-81 kDa, reducing conditions
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt at -20 to -70 °C as supplied. 1 month at 2-8 °C under sterile conditions after reconstitution. 3 months at -20 to -70 °C under sterile conditions after reconstitution
NCBI Full Gene Nametransferrin receptor
NCBI Gene AliasesCD71, IMD46, T9, TFR, TFR1, TR, TRFR, p90

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Integrin β1 activity controls colony morphology during human pluripotent stem cell state transitionsStem cell reportsJuly 8, 2025Taskinen ME, Pasquier N, Stubb A, Joshi S, Chastney MR, Rasila P, Vahlman S, Sokka J, Lönnberg T, Mikkola L, et al.

(2) Assembly of a stem cell-derived human postimplantation embryo modelNature protocolsJanuary 1, 2025Gantner CW, Weatherbee BAT, Wang Y, Zernicka-Goetz M.

(3) Quantification and Site-Specific Analysis of Co-occupied N- and O-GlycopeptidesJournal of Proteome ResearchDecember 6, 2024Joann Chongsaritsinsuk, Valentina Rangel-Angarita, Taryn M. Lucas, Keira E. Mahoney, Olivia M. Enny, Mitchelle Katemauswa, Stacy A. MalakerSigma-Aldrich (E0518), Invitrogen (RP-43132), Athens Research & Technology (16–16–080513), and R&D systems (3188-AT-100MG), respectively. Bovine Fetuin-A (P12763) was purchased from Promega (V4961). The plasmids for His-tagged

(4) INA03: A Potent Transferrin-Competitive Antibody-Drug Conjugate against CD71 for Safer Acute Leukemia TreatmentMolecular cancer therapeuticsAugust 1, 2024Bratti M, Stubbs E, Kolodych S, Souchet H, Kelly L, Merlin J, Marchal M, Castellano R, Josselin E, Pasquer H, et al.

(5) Development of a first-in-class antibody and a specific assay for α-1,6-fucosylated prostate-specific antigenScientific reportsJuly 17, 2024Halldórsson S, Hillringhaus L, Hojer C, Muranyi A, Schraeml M, Lange MS, Tabarés G.

(6) Quantification and site-specific analysis of co-occupied N- and O-glycopeptidesbioRxiv : the preprint server for biologyJuly 7, 2024Chongsaritsinsuk J, Rangel-Angarita V, Mahoney KE, Lucas TM, Enny OM, Katemauswa M, Malaker SA.

(7) Assembly of complete mouse embryo models from embryonic and induced stem cell types in vitroNature protocolsDecember 1, 2023Lau KYC, Amadei G, Zernicka-Goetz M.in-house, see ‘Reagent setup’) DMEM/F12 (Gibco, cat. no. 21331–020)Apo-transferrin (R&D Systems, cat. no. 3188-AT-100MG)Bovine albumin fraction V (Thermo Fisher Scientific, cat. no. 15260037)Human insulin solution (Sigma-Aldrich,

(8) The VDR FokI (rs2228570) polymorphism is involved in Parkinson's diseaseJournal of the neurological sciencesSeptember 15, 2021Agliardi C, Guerini FR, Zanzottera M, Bolognesi E, Meloni M, Riboldazzi G, Zangaglia R, Sturchio A, Casali C, Di Lorenzo C, et al.

(9) DUX4 Transcript Knockdown with Antisense 2'-O-Methoxyethyl Gapmers for the Treatment of Facioscapulohumeral Muscular DystrophyMolecular therapy : the journal of the American Society of Gene TherapyFebruary 3, 2021Lim KRQ, Bittel A, Maruyama R, Echigoya Y, Nguyen Q, Huang Y, Dzierlega K, Zhang A, Chen YW, Yokota T.

(10) Expression of Amyloidogenic Transthyretin Drives Hepatic Proteostasis Remodeling in an Induced Pluripotent Stem Cell Model of Systemic Amyloid DiseaseStem cell reportsAugust 11, 2020Giadone RM, Liberti DC, Matte TM, Rosarda JD, Torres-Arancivia C, Ghosh S, Diedrich JK, Pankow S, Skvir N, Jean JC, et al.

(11) Molecular Mechanisms of Membrane Curvature Sensing by a Disordered ProteinJournal of the American Chemical SocietyJuly 3, 2019Zeno WF, Thatte AS, Wang L, Snead WT, Lafer EM, Stachowiak JC.

(12) Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastomaThe Journal of clinical investigationJanuary 1, 2011Staquicini FI, Ozawa MG, Moya CA, Driessen WH, Barbu EM, Nishimori H, Soghomonyan S, Flores LG 2nd, Liang X, Paolillo V, et al.

Be the First to Write a Review!

Human Apo-Transferrin Protein, CF from R&D Systems, a Bio-Techne Brand

R&D Systems, a Bio-Techne Brand

Citations (12)

Reviews

Human Apo-Transferrin Protein, CF from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map